Tirzepatide is injected subcutaneously into the abdomen, thigh, or upper arm using a pre-filled, single-dose pen
How to be thoughtful when prescribing
But here's what's important: muscle loss is not a direct effect of GLP-1 medications
The starter doses are mainly used to help your body adjust to the medication , although some people may notice early appetite suppression or initial weight loss
The potential found within GHK is significant, yet the fact that it is lost over time creates a serious problem for many people
Moreover, whereas GIPR antagonism alone failed to prevent the effects of this higher dose of tirzepatide, a combined effect of both antagonists was seen, preventing glucose lowering in response to tirzepatide